Join the Uterine Leiomyomata / Fibroids group to help and get support from people like you.
Uterine Leiomyomata / Fibroids News
Related terms: Uterine Fibroid, Fibroid
Exercise Beneficial to Mental Health of Women With Chronic Pelvic Pain
TUESDAY, March 4, 2025 – Engaging in physical activity seems to be beneficial to the mental health of women with chronic pelvic pain disorders (CPPD), according to a study published online Feb. 26...
Exercise Boosts Mental Health Of Women With Chronic Pelvic Pain
MONDAY, March 3, 2025 – Physical activity can improve the mental well-being of women living with chronic pelvic pain disorders like endometriosis and uterine fibroids, a new study says. Activities...
Risk for Premature Mortality Increased With History of Endometriosis
THURSDAY, Nov. 21, 2024 – Women with a history of endometriosis and uterine fibroids may have an increased risk for premature mortality, according to a study published online Nov. 20 in The BMJ....
Fibroids, Endometriosis Linked to Shorter Life Spans
FRIDAY, Nov. 22, 2024 — Two conditions common during women's childbearing years may increase their odds for serious illness and premature death, a large study shows. Drawing on data from close to 1...
Uterus Transplant Feasible, Linked to High Rate of Live Birth
MONDAY, Aug. 19, 2024 – Uterus transplant is feasible and is associated with high rates of live birth after successful graft survival, according to a study published online Aug. 15 in the Journal of...
Survey: Few Women With Uterine Fibroids Offered Less Invasive Treatment Options
WEDNESDAY, July 24, 2024 – Most U.S. women with uterine fibroids report being offered hysterectomies over minimally invasive treatments, according to survey results released by the Society of...
Women With Fibroids Often Offered Hysterectomy Over Less Invasive Treatment
THURSDAY, July 11, 2024 – Women with uterine fibroids are often told hysterectomy is the best treatment, even though less invasive options are available, a new study finds. More than half (53%) of...
FDA Approves Myfembree as the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids
BASEL, Switzerland and NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) – Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Approves Oriahnn (elagolix/estradiol/norethindrone acetate and elagolix) for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-Menopausal Women
NORTH CHICAGO, Ill., May 29, 2020 /PRNewswire/ – AbbVie (NYSE: ABBV), in cooperation with Neurocrine Biosciences, Inc. (Nasdaq: NBIX), announced that the U.S. Food and Drug Administration (FDA)...